May help to prevent
progression from prediabetes
Used alone and in combination
May require caution for some
with hepatic or renal disease
|
|
A trial with oral medication therapies suggested that over a
period of three years prediabetes patients maintained their
status and normoglycemia significantly better in the
medication treated group when compared with placebo.[i]
A study of troglitazone (now off the market) suggested that
the preventive effect of medications may last well beyond a
lengthy wash-out period, suggesting the potential to prevent
diabetes in prediabetes patients.[ii]
Injection medications
Now let's talk about injectable medications:
Used alone or in combination with other
medications
|
|
Insulin therapy in type 2 diabetes is reserved for higher
glucose levels (>8% HbA1c, symptomatic hyperglycemia, and
elevated fasting or high postprandial glucose levels) and
for use in patients who do not achieve adequate glucose
control on other therapies (6.5%-8.5% despite oral
medication therapy), including an elevated fasting glucose
level. There are five main categories of injected insulin
therapies: rapid-acting, short-acting, intermediate-acting,
long-acting, and premixed. Insulin therapy is the treatment
of choice for patients with both diabetes and renal
diseases. Careful monitoring is suggested when insulin is
used alone or in combination with other therapies.